Biodexa Pharmaceticals
Price & Volume
Stats
See moreOpen | $1.32 |
Previous Close | $1.29 |
Day Range | $1.30-$1.32 |
52W Range | $1.28-$73.99 |
Market Cap | $996,202 |
Shares Short | 46,949 |
Financials
See moreRevenue (12 Mos) | $83,000 |
Revenue Growth (YoY) | -64.1% |
Gross Profit (12 Mos) | $145,000 |
Diluted EPS | -$77.66 |
News
See moreYahoo Finance • 19 days ago
Biodexa Announces Successful Outcome of a Type C Meeting with FDA Regarding the Phase 3 Program for eRapa in FAP
Yahoo Finance • 23 days ago
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
Yahoo Finance • last month
Biodexa Announces Allowance of U.S. Patent Covering Oral Rapamycin Nanoparticle Preparations (“eRapa”) and Use
Yahoo Finance • last month
Presenting on the Emerging Growth Conference 79 Day 2 on February 19 Register Now
About
CEO | Mr. Stephen Anthony Stamp |
CFO | Mr. Stephen Anthony Stamp |
Address | 1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |
